Published in Nature on December 14, 1978
Fibronectins: multifunctional modular glycoproteins. J Cell Biol (1982) 8.05
Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76
Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci U S A (1989) 3.94
Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc Natl Acad Sci U S A (1992) 3.37
Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11
Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A (1983) 2.97
Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 2.79
Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun (1999) 2.28
Experimental Staphylococcus aureus arthritis in mice. Infect Immun (1991) 2.24
Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun (1982) 2.02
Binding of human fibronectin to group A, C, and G streptococci. Infect Immun (1983) 2.01
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
Binding of fibronectin to Staphylococcus strains. Infect Immun (1983) 1.96
Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect Immun (1986) 1.93
Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase. Infect Immun (1985) 1.86
Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence. Infect Immun (1984) 1.86
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen. Infect Immun (1992) 1.68
Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66
Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol (1983) 1.63
Fibronectin binding to a Streptococcus pyogenes strain. J Bacteriol (1984) 1.60
Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun (1986) 1.58
Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med (1981) 1.53
Interaction of human plasma fibronectin with cariogenic and non-cariogenic oral streptococci. Infect Immun (1983) 1.53
Binding of collagen to Staphylococcus aureus Cowan 1. J Bacteriol (1986) 1.51
Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect Immun (1996) 1.51
Attachment of Treponema pallidum to fibronectin, laminin, collagen IV, and collagen I, and blockage of attachment by immune rabbit IgG. Br J Vener Dis (1984) 1.51
Fibronectin binding to protein A-containing staphylococci. Infect Immun (1981) 1.50
Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med J (2000) 1.49
Role of fibronectin in attachment of Streptococcus pyogenes and Escherichia coli to human cell lines and isolated oral epithelial cells. Infect Immun (1985) 1.41
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Binding sites for streptococci and staphylococci in fibronectin. Infect Immun (1984) 1.41
Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect Immun (1985) 1.40
Identification of Porphyromonas gingivalis components that mediate its interactions with fibronectin. J Bacteriol (1991) 1.39
Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest (1990) 1.37
Acquisition of alpha 1-Antitrypsin by a pathogenic strain of Trichomonas vaginalis. Infect Immun (1983) 1.37
Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface. Infect Immun (2002) 1.36
Specific attachment of Staphylococcus aureus to immobilized fibronectin. Infect Immun (1986) 1.31
Phagocytosis of gelatin-latex particles by a murine macrophage line is dependent on fibronectin and heparin. J Cell Biol (1981) 1.30
Rapid identification of fibronectin, vitronectin, laminin, and collagen cell surface binding proteins on coagulase-negative staphylococci by particle agglutination assays. J Clin Microbiol (1992) 1.25
Interaction of viral envelope glycoproteins with fibronectin. Infect Immun (1983) 1.21
The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells. J Exp Med (1991) 1.21
In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment. Infect Immun (1985) 1.21
Interactions of fibronectin with Treponema pallidum. Genitourin Med (1985) 1.19
Fibronectin-binding protein of Streptococcus equi subsp. zooepidemicus. Infect Immun (1996) 1.18
The major pilin subunit of the AAF/II fimbriae from enteroaggregative Escherichia coli mediates binding to extracellular matrix proteins. Infect Immun (2008) 1.18
Collagen binding in clinical isolates of Staphylococcus aureus. J Clin Microbiol (1987) 1.18
Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest (1990) 1.17
Inhibition of Staphylococcus aureus adherence to collagen under dynamic conditions. Infect Immun (1999) 1.17
Serodiagnosis of Streptococcus faecalis endocarditis by immunoblotting of surface protein antigens. J Clin Microbiol (1987) 1.12
Stretching fibronectin fibres disrupts binding of bacterial adhesins by physically destroying an epitope. Nat Commun (2010) 1.12
Structural biology of Gram-positive bacterial adhesins. Protein Sci (2011) 1.07
Immunochemical characterization of human plasma fibronectin. Biochem J (1980) 1.06
Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun (1985) 1.05
Release of fibronectin-lipoteichoic acid complexes from group A streptococci with penicillin. Infect Immun (1986) 1.05
Binding of Staphylococcus aureus by human serum spreading factor in an in vitro assay. Infect Immun (1986) 1.02
Isolation and characterization of fibronectin-binding sites of Borrelia garinii N34. Infect Immun (1995) 1.02
Collagen binding to Staphylococcus aureus. Infect Immun (1986) 1.01
Cerebrospinal fluid concentration of fibronectin in meningitis. J Clin Pathol (1991) 1.01
Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms. J Clin Invest (1990) 1.00
Staphylococcus saprophyticus hemagglutinin binds fibronectin. Infect Immun (1994) 0.99
Treponema denticola interactions with host proteins. J Oral Microbiol (2012) 0.98
Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process. Microbiol Mol Biol Rev (2002) 0.95
Plasma fibronectin concentrations in patients with human immunodeficiency virus infection. J Clin Pathol (1990) 0.94
Interaction of soluble fibronectin with group B streptococci. Infect Immun (1987) 0.93
Binding of collagens to an enterotoxigenic strain of Escherichia coli. Infect Immun (1990) 0.92
Long polar fimbriae of enterohemorrhagic Escherichia coli O157:H7 bind to extracellular matrix proteins. Infect Immun (2011) 0.92
Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis. Langmuir (2010) 0.91
C1q, a subunit of the first component of complement, enhances binding of plasma fibronectin to bacteria. Infect Immun (1985) 0.91
A tactile response in Staphylococcus aureus. Biophys J (2010) 0.89
Isolation of Enterococcus faecalis clinical isolates that efficiently adhere to human bladder carcinoma T24 cells and inhibition of adhesion by fibronectin and trypsin treatment. Infect Immun (1999) 0.89
Reversal of fibronectin and opsonic deficiency in patients. A controlled study. Ann Surg (1984) 0.89
Association of fibronectin with carboxy-group-modified proteins in vitro. Biochem J (1982) 0.88
Rapid detection of methicillin-resistant Staphylococcus aureus strains not identified by slide agglutination tests. J Clin Microbiol (1994) 0.88
Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections. J Virol (2007) 0.86
Pathogenesis and management of lung disease in cystic fibrosis. J R Soc Med (1991) 0.85
Identification of a beta 1 integrin on Mycobacterium avium-Mycobacterium intracellulare. Infect Immun (1992) 0.83
Effect of milk on fibronectin and collagen type I binding to Staphylococcus aureus and coagulase-negative staphylococci isolated from bovine mastitis. J Clin Microbiol (1989) 0.83
Stuck in the Middle: Fibronectin-Binding Proteins in Gram-Positive Bacteria. Front Microbiol (2016) 0.83
Studies on fibronectin in inflammatory vs non-inflammatory polymorphonuclear leucocytes of patients with rheumatoid arthritis. II. Synthesis and release of fibronectin in vitro. Clin Exp Immunol (1985) 0.83
Effect of specific antibody on adherence of Staphylococcus aureus to bovine mammary epithelial cells. Infect Immun (1992) 0.80
Hybrid nanostructured coating for increased resistance of prosthetic devices to staphylococcal colonization. Nanoscale Res Lett (2013) 0.79
Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents. Antimicrob Agents Chemother (2001) 0.79
Levels of circulating fibronectin receptor in adult and pediatric patients with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (1994) 0.79
Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases. Immunology (1999) 0.78
Participation of integrin α5β1 in the fibronectin-mediated adherence of enteroaggregative Escherichia coli to intestinal cells. Biomed Res Int (2014) 0.78
Circulating fibronectin and fibronectin receptor in children with pertussis. J Clin Pathol (1994) 0.77
Flagellin and GroEL mediates in vitro binding of an atypical enteropathogenic Escherichia coli to cellular fibronectin. BMC Microbiol (2015) 0.77
Expression of the alpha 5 beta 1 fibronectin receptor on T lymphocytes of patients with HIV-1 infection. J Clin Pathol (1996) 0.75
The Role of Fibronectin in the Adherence and Inflammatory Response Induced by Enteroaggregative Escherichia coli on Epithelial Cells. Front Cell Infect Microbiol (2016) 0.75
Comparative influence of blood-borne nonbacterial particles and Staphylococcus aureus on fibronectin, complement and immunoglobulin. Ann Surg (1982) 0.75
Fibronectin enhances transfection of Staphylococcus aureus. Appl Environ Microbiol (1985) 0.75
The Fibronectin-Binding Protein Fnm Contributes to Adherence to Extracellular Matrix Components and Virulence of Enterococcus faecium. Infect Immun (2015) 0.75
Fibronectin in exudative pleural effusions. J Clin Pathol (1982) 0.75
A fibronectin-binding glycoprotein from human platelet membranes. Biochem J (1982) 0.75
Modifications of plasma fibronectin in cystic fibrosis patients. Infect Immun (1991) 0.75
A detailed guideline for the fabrication of single bacterial probes used for atomic force spectroscopy. Eur Phys J E Soft Matter (2015) 0.75
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
Bacterial plasminogen activators and receptors. FEMS Microbiol Rev (2001) 2.19
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13
Binding of human fibronectin to group A, C, and G streptococci. Infect Immun (1983) 2.01
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase. Infect Immun (1985) 1.86
Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification Of eight NSVAIG - S motifs in the amino-terminal half of the protein involved in collagen binding. Mol Microbiol (2000) 1.55
Purification and characterisation of a plasmin-sensitive surface protein of Staphylococcus aureus. Eur J Biochem (1996) 1.54
Immunological interspecies cross-reactions of fibroblast surface antigen (fibronectin). Immunochemistry (1976) 1.44
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br J Cancer (1994) 1.44
Binding sites for streptococci and staphylococci in fibronectin. Infect Immun (1984) 1.41
Isolation of a tryptic fragment containing the collagen-binding site of plasma fibronectin. J Biol Chem (1979) 1.35
Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol (1983) 1.33
Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9. Int J Cancer (1987) 1.30
Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med (1978) 1.28
Polypeptides of a glycoprotein antigen (SF) present in serum and surface of normal but not of transformed chicken fibroblasts. Biochim Biophys Acta (1975) 1.25
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct (1976) 1.23
Development of brown fat cells in monolayer culture. I. Morphological and biochemical distinction from white fat cells in culture. Exp Cell Res (1983) 1.19
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. Br J Cancer (1989) 1.18
Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix. Infect Immun (1995) 1.12
Interaction of Haemophilus influenzae with the mammalian extracellular matrix. J Infect Dis (1996) 1.11
Expression of pls, a gene closely associated with the mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect Immun (2001) 1.11
A novel lectin-independent interaction of P fimbriae of Escherichia coli with immobilized fibronectin. FEBS Lett (1989) 1.10
Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin. J Infect Dis (1992) 1.10
Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab Invest (1988) 1.10
The relationship between the keratocyst antigen (KCA) and keratin. J Oral Pathol (1986) 1.06
Multifunctional nature of P fimbriae of uropathogenic Escherichia coli: mutations in fsoE and fsoF influence fimbrial binding to renal tubuli and immobilized fibronectin. Mol Microbiol (1991) 1.03
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer (1994) 1.03
Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J Surg Oncol (1992) 1.02
Demonstration and partial characterization of a novel soluble antigen present in keratocysts. Oncodev Biol Med (1982) 0.98
Tumour markers CA 19-9 and CA 50 in digestive tract malignancies. Scand J Gastroenterol (1992) 0.98
Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. Methods (2000) 0.97
Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Eur J Cancer (1993) 0.96
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer (1987) 0.95
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9. Anticancer Res (1996) 0.94
Antibacterial activities of temporin A analogs. FEBS Lett (2000) 0.91
Tumour marker CA 125 in patients with digestive tract malignancies. Scand J Clin Lab Invest (1991) 0.89
Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. J Crit Care (1999) 0.89
Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg (1999) 0.89
Proteolytic activity in leg ulcer exudate. Exp Dermatol (1993) 0.89
Intramucosal pH and endotoxin and cytokine release in severe acute pancreatitis. Shock (2000) 0.87
Immobilization of plasminogen on Escherichia coli flagella. FEMS Microbiol Lett (1993) 0.86
Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I. Pediatr Res (1994) 0.86
Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein. Br J Obstet Gynaecol (1983) 0.84
Activation of interstitial collagenase, MMP-1, by Staphylococcus aureus cells having surface-bound plasmin: a novel role of plasminogen receptors of bacteria. FEBS Lett (1999) 0.84
Is swimming exercise or cold exposure for rats? Acta Physiol Scand (1986) 0.84
Tumour markers in pancreatic cancer. Ann Chir Gynaecol (1989) 0.83
Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure. Clin Nephrol (2004) 0.83
Exogenous fibronectin is not required for organogenesis in vitro. In Vitro (1983) 0.82
Cellular origin of fibronectin in interspecies hybrid kidneys. J Cell Biol (1984) 0.81
Comparison of genotypes of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis (2005) 0.81
Reactivity of hybridoma antibodies with amniotic and plasma fibronectin. Scand J Immunol (1980) 0.81
Beta-adrenergic stimulation of fatty acid release from brown fat cells differentiated in monolayer culture. Life Sci (1986) 0.81
Noncollagenous matrix components of glomeruli in congenital nephrotic syndrome of the Finnish type: evidence of abnormal splitting of nidogen? Exp Nephrol (1997) 0.81
Valgus deformity and proximal subluxation of the rheumatoid elbow: a radiographic 15 year follow up study of 148 elbows. Ann Rheum Dis (2001) 0.81
Characterization of fibronectin on human spermatozoa. Hoppe Seylers Z Physiol Chem (1984) 0.80
Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett (1999) 0.80
Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects. Obstet Gynecol (1998) 0.80
Synthesis and antimicrobial activity of the symmetric dimeric form of Temporin A based on 3-N,N-di(3-aminopropyl)amino propanoic acid as the branching unit. Bioorg Med Chem (2001) 0.80
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors. Pediatr Res (1995) 0.80
Tissue interactions of Escherichia coli adhesins. Antonie Van Leeuwenhoek (1988) 0.80
The cellular origin of fibronectin in the basement membrane zone of developing tooth. J Embryol Exp Morphol (1986) 0.79
The ovarian cancer associated antigen CA 125 in patients with pleural effusions. Eur J Cancer Clin Oncol (1988) 0.79
Adipose, muscle and lung tissue lipoprotein lipase activities in young streptozotocin treated rats. Horm Metab Res (1980) 0.79
Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Microbiol Infect Dis (1995) 0.78
Plasma interleukin-8, interleukin-10, and E-selectin levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Microbiol Infect Dis (1997) 0.78
Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. A prospective study. Scand J Gastroenterol (1991) 0.78
Evaluation of three slide agglutination tests for rapid identification of Staphylococcus aureus. Acta Vet Scand (1991) 0.78
Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy. Br J Cancer (1990) 0.78
Temperature responses of rats to treadmill exercise, and the effect of thermoregulatory capacity. Acta Physiol Scand (1982) 0.77
Dental papilla cells synthesize but do not deposit fibronectin in culture. J Dent Res (1987) 0.77
Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer (1995) 0.77
Effects of the adrenergic nervous system on training-induced cardiac enlargement, and on the intrinsic rate and phenylephrine sensitivity of isolated rat atria. Can J Physiol Pharmacol (1982) 0.76
Effect of chemical modification of arginine and lysine residues of fibronectin on its antigenic and gelatin-binding activity. Mol Immunol (1983) 0.76
Isolation of a novel cell-attachment and spreading-promoting protein from human serum. Biochem J (1985) 0.75
Biphasic reduction and concanavalin A binding properties of serum alpha-fetoprotein in preterm and term infants. J Pediatr (1991) 0.75
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformations. Scand J Clin Lab Invest (1983) 0.75
Tumour markers in pancreatic cancer. Scand J Gastroenterol Suppl (1986) 0.75
Early detection of malignant transformation after neonatal sacrococcygeal teratoma. Pediatr Hematol Oncol (1987) 0.75
Tumour markers in gastric cancer. Ann Chir Gynaecol (1989) 0.75
No endotoxin detected in plasma of patients with ankylosing spondylitis. Ann Rheum Dis (1997) 0.75
Disulfide-bonded dimerization of fibronectin in vitro. Eur J Biochem (1991) 0.75
Non-specific binding compromises the purification yields of leukemic B-cells in chronic lymphocytic leukemia: prevention by collagen coating. Eur J Haematol (1998) 0.75
Modification of training-induced responses by repeated norepinephrine injections in rats. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.75
The single chain nature of human group specific (Gc) protein. Biochim Biophys Acta (1972) 0.75